Bank of New York Mellon’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
HP
NW
QC
JDLA
Bank of New York Mellon's PYXS Position: Q2 2026 in Review
Bank of New York Mellon held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 133,996 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #3852.
Bank of New York Mellon first reported a position in PYXS in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.03M in Q2 2024. 33 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.
- Bank of New York Mellon held 133,996 shares of Pyxis Oncology worth $403K as of Q2 2026.
- Bank of New York Mellon left its Pyxis Oncology share count unchanged in Q2 2026.
- Pyxis Oncology made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3852 holding.
- Bank of New York Mellon first reported a position in Pyxis Oncology in Q4 2021 and has held it in 16 quarters since.
- Bank of New York Mellon's Pyxis Oncology position peaked at $1.03M in Q2 2024.
- 33 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.